tiprankstipranks
Trending News
More News >
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
US Market
Advertisement

OrthoPediatrics (KIDS) Earnings Dates, Call Summary & Reports

Compare
116 Followers

Earnings Data

Report Date
Nov 05, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-0.25
Last Year’s EPS
-0.18
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since: -4.95%|
Earnings Call Sentiment|Positive
The earnings call depicted a strong performance in terms of revenue growth, especially in the Scoliosis and OPSB segments, with promising expansions and product launches. However, challenges like a decline in gross margins and restructuring costs were noted. Overall, the positive aspects and growth initiatives appeared to outweigh the identified challenges.
Company Guidance -
Q3 2025
During OrthoPediatrics Corporation's second quarter 2025 earnings call, the company provided updated guidance and highlighted several key metrics. They reported record revenue growth of 16% year-over-year, with total revenue reaching $61.1 million. Strong performances were noted in their Scoliosis and Trauma segments, with Scoliosis revenue increasing by 35% and Trauma and Deformity revenue growing by 10%. International sales also grew by 12%, driven by increased surgical demand in Europe and the Middle East. The company raised its full-year revenue guidance to a range of $237 million to $242 million and maintained its adjusted EBITDA target of $15 million to $17 million. OrthoPediatrics expects to achieve positive free cash flow in the fourth quarter of 2025 and aims for full-year free cash flow breakeven in 2026. Additionally, they expanded their clinic footprint significantly, surpassing their initial 2025 expansion goals.
Record Revenue Growth
OrthoPediatrics achieved record revenue with global growth of 16% in Q2 2025, driven by market share gains across all business segments.
Scoliosis Business Expansion
The Scoliosis segment demonstrated a 35% growth, driven by increased sales of RESPONSE, ApiFix, and 7D technologies.
OPSB Expansion Success
The OPSB segment experienced over 20% growth and expanded into two large markets, New York City and California, as well as internationally in Ireland.
FDA Approvals and Product Launches
Received FDA approval for sterile products, and the first surgical case using the 3P Pediatric Plating Platform Hip system was completed.
Improved EBITDA
Adjusted EBITDA improved by 50%, increasing from $2.6 million in Q2 2024 to $4.1 million in Q2 2025.

OrthoPediatrics (KIDS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

KIDS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 05, 2025
2025 (Q3)
-0.25 / -
-0.18
Aug 05, 2025
2025 (Q2)
-0.29 / -0.11
-0.2352.17% (+0.12)
May 07, 2025
2025 (Q1)
-0.44 / -0.39
-0.3-30.00% (-0.09)
Mar 04, 2025
2024 (Q4)
-0.30 / -0.29
-0.23-26.09% (-0.06)
Nov 06, 2024
2024 (Q3)
-0.23 / -0.18
-0.13-38.46% (-0.05)
Aug 05, 2024
2024 (Q2)
-0.26 / -0.23
-0.19-21.05% (-0.04)
May 06, 2024
2024 (Q1)
-0.41 / -0.30
-0.29-3.45% (-0.01)
Mar 06, 2024
2023 (Q4)
-0.27 / -0.23
-0.3228.13% (+0.09)
Nov 06, 2023
2023 (Q3)
-0.21 / -0.13
-0.05-160.00% (-0.08)
Jul 31, 2023
2023 (Q2)
-0.20 / -0.19
-0.17-11.76% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

KIDS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$20.19$17.90-11.34%
May 07, 2025
$22.18$23.08+4.06%
Mar 04, 2025
$22.89$25.61+11.88%
Nov 06, 2024
$30.95$27.49-11.18%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does OrthoPediatrics Corp (KIDS) report earnings?
OrthoPediatrics Corp (KIDS) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).
    What is OrthoPediatrics Corp (KIDS) earnings time?
    OrthoPediatrics Corp (KIDS) earnings time is at Nov 05, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is KIDS EPS forecast?
          KIDS EPS forecast for the fiscal quarter 2025 (Q3) is -0.25.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis